Medical Care
Global Prostate Cancer Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Apr 16, 25
- ID: 198569
- Pages: 93
- Figures: 100
- Views: 2
The global Prostate Cancer Diagnostics market size was US$ 15590 million in 2024 and is forecast to a readjusted size of US$ 26180 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.
Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
Market competition is intense. Genomic Health, Abbott, OPKO, Siemens Healthcare, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. Those key players got about 4% market shares. North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49%. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28%.
The global Prostate Cancer Diagnostics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
OPKO
Genomic Health
Abbott
Beckman Coulter
Siemens Healthcare
bioMeriux
Roche
MDx Health
DiaSorin
Myriad Genetics
Ambry Genetics
By Type: (Dominant Segment vs High-Margin Innovation)
Tumor Biomarker Tests
Imaging
Biopsy
Other
By Application: (Core Demand Driver vs Emerging Opportunity)
Age Below 55
Age 55-75
Age Above 75
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., OPKO in Europe)
- Emerging Product Trends: Tumor Biomarker Tests adoption vs. Imaging premiumization
- Demand-Side Dynamics: Age Below 55 growth in China vs. Age 55-75 potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Prostate Cancer Diagnostics market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Imaging in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Age 55-75 in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Prostate Cancer Diagnostics value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.
Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
Market competition is intense. Genomic Health, Abbott, OPKO, Siemens Healthcare, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. Those key players got about 4% market shares. North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49%. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28%.
The global Prostate Cancer Diagnostics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
OPKO
Genomic Health
Abbott
Beckman Coulter
Siemens Healthcare
bioMeriux
Roche
MDx Health
DiaSorin
Myriad Genetics
Ambry Genetics
By Type: (Dominant Segment vs High-Margin Innovation)
Tumor Biomarker Tests
Imaging
Biopsy
Other
By Application: (Core Demand Driver vs Emerging Opportunity)
Age Below 55
Age 55-75
Age Above 75
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., OPKO in Europe)
- Emerging Product Trends: Tumor Biomarker Tests adoption vs. Imaging premiumization
- Demand-Side Dynamics: Age Below 55 growth in China vs. Age 55-75 potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Prostate Cancer Diagnostics market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Imaging in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Age 55-75 in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Prostate Cancer Diagnostics value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Tumor Biomarker Tests
1.2.3 Imaging
1.2.4 Biopsy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Age Below 55
1.3.3 Age 55-75
1.3.4 Age Above 75
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Diagnostics Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Prostate Cancer Diagnostics Revenue Market Share by Region (2020-2025)
2.4 Global Prostate Cancer Diagnostics Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Prostate Cancer Diagnostics Market Size and Prospective (2020-2031)
2.5.2 Europe Prostate Cancer Diagnostics Market Size and Prospective (2020-2031)
2.5.3 China Prostate Cancer Diagnostics Market Size and Prospective (2020-2031)
2.5.4 Japan Prostate Cancer Diagnostics Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Prostate Cancer Diagnostics Market Size and Prospective (2020-2031)
2.5.6 India Prostate Cancer Diagnostics Market Size and Prospective (2020-2031)
2.5.7 Central & South America Prostate Cancer Diagnostics Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Prostate Cancer Diagnostics Historic Market Size by Type (2020-2025)
3.2 Global Prostate Cancer Diagnostics Forecasted Market Size by Type (2026-2031)
3.3 Different Types Prostate Cancer Diagnostics Representative Players
4 Breakdown Data by Application
4.1 Global Prostate Cancer Diagnostics Historic Market Size by Application (2020-2025)
4.2 Global Prostate Cancer Diagnostics Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Prostate Cancer Diagnostics Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Prostate Cancer Diagnostics Players by Revenue (2020-2025)
5.1.2 Global Prostate Cancer Diagnostics Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Prostate Cancer Diagnostics Revenue
5.4 Global Prostate Cancer Diagnostics Market Concentration Analysis
5.4.1 Global Prostate Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnostics Revenue in 2024
5.5 Global Key Players of Prostate Cancer Diagnostics Head office and Area Served
5.6 Global Key Players of Prostate Cancer Diagnostics, Product and Application
5.7 Global Key Players of Prostate Cancer Diagnostics, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Prostate Cancer Diagnostics Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Prostate Cancer Diagnostics Market Size by Type (2020-2025)
6.1.2.2 North America Prostate Cancer Diagnostics Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Prostate Cancer Diagnostics Market Size by Application (2020-2025)
6.1.3.2 North America Prostate Cancer Diagnostics Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Prostate Cancer Diagnostics Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Prostate Cancer Diagnostics Market Size by Type (2020-2025)
6.2.2.2 Europe Prostate Cancer Diagnostics Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Prostate Cancer Diagnostics Market Size by Application (2020-2025)
6.2.3.2 Europe Prostate Cancer Diagnostics Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Prostate Cancer Diagnostics Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Prostate Cancer Diagnostics Market Size by Type (2020-2025)
6.3.2.2 China Prostate Cancer Diagnostics Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Prostate Cancer Diagnostics Market Size by Application (2020-2025)
6.3.3.2 China Prostate Cancer Diagnostics Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Prostate Cancer Diagnostics Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Prostate Cancer Diagnostics Market Size by Type (2020-2025)
6.4.2.2 Japan Prostate Cancer Diagnostics Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Prostate Cancer Diagnostics Market Size by Application (2020-2025)
6.4.3.2 Japan Prostate Cancer Diagnostics Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Prostate Cancer Diagnostics Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Prostate Cancer Diagnostics Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Prostate Cancer Diagnostics Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Prostate Cancer Diagnostics Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Prostate Cancer Diagnostics Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Prostate Cancer Diagnostics Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Prostate Cancer Diagnostics Market Size by Type (2020-2025)
6.6.2.2 India Prostate Cancer Diagnostics Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Prostate Cancer Diagnostics Market Size by Application (2020-2025)
6.6.3.2 India Prostate Cancer Diagnostics Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 OPKO
7.1.1 OPKO Company Details
7.1.2 OPKO Business Overview
7.1.3 OPKO Prostate Cancer Diagnostics Introduction
7.1.4 OPKO Revenue in Prostate Cancer Diagnostics Business (2020-2025)
7.1.5 OPKO Recent Development
7.2 Genomic Health
7.2.1 Genomic Health Company Details
7.2.2 Genomic Health Business Overview
7.2.3 Genomic Health Prostate Cancer Diagnostics Introduction
7.2.4 Genomic Health Revenue in Prostate Cancer Diagnostics Business (2020-2025)
7.2.5 Genomic Health Recent Development
7.3 Abbott
7.3.1 Abbott Company Details
7.3.2 Abbott Business Overview
7.3.3 Abbott Prostate Cancer Diagnostics Introduction
7.3.4 Abbott Revenue in Prostate Cancer Diagnostics Business (2020-2025)
7.3.5 Abbott Recent Development
7.4 Beckman Coulter
7.4.1 Beckman Coulter Company Details
7.4.2 Beckman Coulter Business Overview
7.4.3 Beckman Coulter Prostate Cancer Diagnostics Introduction
7.4.4 Beckman Coulter Revenue in Prostate Cancer Diagnostics Business (2020-2025)
7.4.5 Beckman Coulter Recent Development
7.5 Siemens Healthcare
7.5.1 Siemens Healthcare Company Details
7.5.2 Siemens Healthcare Business Overview
7.5.3 Siemens Healthcare Prostate Cancer Diagnostics Introduction
7.5.4 Siemens Healthcare Revenue in Prostate Cancer Diagnostics Business (2020-2025)
7.5.5 Siemens Healthcare Recent Development
7.6 bioMeriux
7.6.1 bioMeriux Company Details
7.6.2 bioMeriux Business Overview
7.6.3 bioMeriux Prostate Cancer Diagnostics Introduction
7.6.4 bioMeriux Revenue in Prostate Cancer Diagnostics Business (2020-2025)
7.6.5 bioMeriux Recent Development
7.7 Roche
7.7.1 Roche Company Details
7.7.2 Roche Business Overview
7.7.3 Roche Prostate Cancer Diagnostics Introduction
7.7.4 Roche Revenue in Prostate Cancer Diagnostics Business (2020-2025)
7.7.5 Roche Recent Development
7.8 MDx Health
7.8.1 MDx Health Company Details
7.8.2 MDx Health Business Overview
7.8.3 MDx Health Prostate Cancer Diagnostics Introduction
7.8.4 MDx Health Revenue in Prostate Cancer Diagnostics Business (2020-2025)
7.8.5 MDx Health Recent Development
7.9 DiaSorin
7.9.1 DiaSorin Company Details
7.9.2 DiaSorin Business Overview
7.9.3 DiaSorin Prostate Cancer Diagnostics Introduction
7.9.4 DiaSorin Revenue in Prostate Cancer Diagnostics Business (2020-2025)
7.9.5 DiaSorin Recent Development
7.10 Myriad Genetics
7.10.1 Myriad Genetics Company Details
7.10.2 Myriad Genetics Business Overview
7.10.3 Myriad Genetics Prostate Cancer Diagnostics Introduction
7.10.4 Myriad Genetics Revenue in Prostate Cancer Diagnostics Business (2020-2025)
7.10.5 Myriad Genetics Recent Development
7.11 Ambry Genetics
7.11.1 Ambry Genetics Company Details
7.11.2 Ambry Genetics Business Overview
7.11.3 Ambry Genetics Prostate Cancer Diagnostics Introduction
7.11.4 Ambry Genetics Revenue in Prostate Cancer Diagnostics Business (2020-2025)
7.11.5 Ambry Genetics Recent Development
8 Prostate Cancer Diagnostics Market Dynamics
8.1 Prostate Cancer Diagnostics Industry Trends
8.2 Prostate Cancer Diagnostics Market Drivers
8.3 Prostate Cancer Diagnostics Market Challenges
8.4 Prostate Cancer Diagnostics Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Tumor Biomarker Tests
1.2.3 Imaging
1.2.4 Biopsy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Age Below 55
1.3.3 Age 55-75
1.3.4 Age Above 75
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Diagnostics Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Prostate Cancer Diagnostics Revenue Market Share by Region (2020-2025)
2.4 Global Prostate Cancer Diagnostics Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Prostate Cancer Diagnostics Market Size and Prospective (2020-2031)
2.5.2 Europe Prostate Cancer Diagnostics Market Size and Prospective (2020-2031)
2.5.3 China Prostate Cancer Diagnostics Market Size and Prospective (2020-2031)
2.5.4 Japan Prostate Cancer Diagnostics Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Prostate Cancer Diagnostics Market Size and Prospective (2020-2031)
2.5.6 India Prostate Cancer Diagnostics Market Size and Prospective (2020-2031)
2.5.7 Central & South America Prostate Cancer Diagnostics Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Prostate Cancer Diagnostics Historic Market Size by Type (2020-2025)
3.2 Global Prostate Cancer Diagnostics Forecasted Market Size by Type (2026-2031)
3.3 Different Types Prostate Cancer Diagnostics Representative Players
4 Breakdown Data by Application
4.1 Global Prostate Cancer Diagnostics Historic Market Size by Application (2020-2025)
4.2 Global Prostate Cancer Diagnostics Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Prostate Cancer Diagnostics Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Prostate Cancer Diagnostics Players by Revenue (2020-2025)
5.1.2 Global Prostate Cancer Diagnostics Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Prostate Cancer Diagnostics Revenue
5.4 Global Prostate Cancer Diagnostics Market Concentration Analysis
5.4.1 Global Prostate Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnostics Revenue in 2024
5.5 Global Key Players of Prostate Cancer Diagnostics Head office and Area Served
5.6 Global Key Players of Prostate Cancer Diagnostics, Product and Application
5.7 Global Key Players of Prostate Cancer Diagnostics, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Prostate Cancer Diagnostics Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Prostate Cancer Diagnostics Market Size by Type (2020-2025)
6.1.2.2 North America Prostate Cancer Diagnostics Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Prostate Cancer Diagnostics Market Size by Application (2020-2025)
6.1.3.2 North America Prostate Cancer Diagnostics Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Prostate Cancer Diagnostics Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Prostate Cancer Diagnostics Market Size by Type (2020-2025)
6.2.2.2 Europe Prostate Cancer Diagnostics Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Prostate Cancer Diagnostics Market Size by Application (2020-2025)
6.2.3.2 Europe Prostate Cancer Diagnostics Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Prostate Cancer Diagnostics Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Prostate Cancer Diagnostics Market Size by Type (2020-2025)
6.3.2.2 China Prostate Cancer Diagnostics Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Prostate Cancer Diagnostics Market Size by Application (2020-2025)
6.3.3.2 China Prostate Cancer Diagnostics Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Prostate Cancer Diagnostics Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Prostate Cancer Diagnostics Market Size by Type (2020-2025)
6.4.2.2 Japan Prostate Cancer Diagnostics Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Prostate Cancer Diagnostics Market Size by Application (2020-2025)
6.4.3.2 Japan Prostate Cancer Diagnostics Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Prostate Cancer Diagnostics Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Prostate Cancer Diagnostics Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Prostate Cancer Diagnostics Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Prostate Cancer Diagnostics Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Prostate Cancer Diagnostics Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Prostate Cancer Diagnostics Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Prostate Cancer Diagnostics Market Size by Type (2020-2025)
6.6.2.2 India Prostate Cancer Diagnostics Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Prostate Cancer Diagnostics Market Size by Application (2020-2025)
6.6.3.2 India Prostate Cancer Diagnostics Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 OPKO
7.1.1 OPKO Company Details
7.1.2 OPKO Business Overview
7.1.3 OPKO Prostate Cancer Diagnostics Introduction
7.1.4 OPKO Revenue in Prostate Cancer Diagnostics Business (2020-2025)
7.1.5 OPKO Recent Development
7.2 Genomic Health
7.2.1 Genomic Health Company Details
7.2.2 Genomic Health Business Overview
7.2.3 Genomic Health Prostate Cancer Diagnostics Introduction
7.2.4 Genomic Health Revenue in Prostate Cancer Diagnostics Business (2020-2025)
7.2.5 Genomic Health Recent Development
7.3 Abbott
7.3.1 Abbott Company Details
7.3.2 Abbott Business Overview
7.3.3 Abbott Prostate Cancer Diagnostics Introduction
7.3.4 Abbott Revenue in Prostate Cancer Diagnostics Business (2020-2025)
7.3.5 Abbott Recent Development
7.4 Beckman Coulter
7.4.1 Beckman Coulter Company Details
7.4.2 Beckman Coulter Business Overview
7.4.3 Beckman Coulter Prostate Cancer Diagnostics Introduction
7.4.4 Beckman Coulter Revenue in Prostate Cancer Diagnostics Business (2020-2025)
7.4.5 Beckman Coulter Recent Development
7.5 Siemens Healthcare
7.5.1 Siemens Healthcare Company Details
7.5.2 Siemens Healthcare Business Overview
7.5.3 Siemens Healthcare Prostate Cancer Diagnostics Introduction
7.5.4 Siemens Healthcare Revenue in Prostate Cancer Diagnostics Business (2020-2025)
7.5.5 Siemens Healthcare Recent Development
7.6 bioMeriux
7.6.1 bioMeriux Company Details
7.6.2 bioMeriux Business Overview
7.6.3 bioMeriux Prostate Cancer Diagnostics Introduction
7.6.4 bioMeriux Revenue in Prostate Cancer Diagnostics Business (2020-2025)
7.6.5 bioMeriux Recent Development
7.7 Roche
7.7.1 Roche Company Details
7.7.2 Roche Business Overview
7.7.3 Roche Prostate Cancer Diagnostics Introduction
7.7.4 Roche Revenue in Prostate Cancer Diagnostics Business (2020-2025)
7.7.5 Roche Recent Development
7.8 MDx Health
7.8.1 MDx Health Company Details
7.8.2 MDx Health Business Overview
7.8.3 MDx Health Prostate Cancer Diagnostics Introduction
7.8.4 MDx Health Revenue in Prostate Cancer Diagnostics Business (2020-2025)
7.8.5 MDx Health Recent Development
7.9 DiaSorin
7.9.1 DiaSorin Company Details
7.9.2 DiaSorin Business Overview
7.9.3 DiaSorin Prostate Cancer Diagnostics Introduction
7.9.4 DiaSorin Revenue in Prostate Cancer Diagnostics Business (2020-2025)
7.9.5 DiaSorin Recent Development
7.10 Myriad Genetics
7.10.1 Myriad Genetics Company Details
7.10.2 Myriad Genetics Business Overview
7.10.3 Myriad Genetics Prostate Cancer Diagnostics Introduction
7.10.4 Myriad Genetics Revenue in Prostate Cancer Diagnostics Business (2020-2025)
7.10.5 Myriad Genetics Recent Development
7.11 Ambry Genetics
7.11.1 Ambry Genetics Company Details
7.11.2 Ambry Genetics Business Overview
7.11.3 Ambry Genetics Prostate Cancer Diagnostics Introduction
7.11.4 Ambry Genetics Revenue in Prostate Cancer Diagnostics Business (2020-2025)
7.11.5 Ambry Genetics Recent Development
8 Prostate Cancer Diagnostics Market Dynamics
8.1 Prostate Cancer Diagnostics Industry Trends
8.2 Prostate Cancer Diagnostics Market Drivers
8.3 Prostate Cancer Diagnostics Market Challenges
8.4 Prostate Cancer Diagnostics Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Prostate Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Prostate Cancer Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Prostate Cancer Diagnostics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Prostate Cancer Diagnostics Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Prostate Cancer Diagnostics Revenue Share by Region (2020-2025)
Table 6. Global Prostate Cancer Diagnostics Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Prostate Cancer Diagnostics Revenue Share Forecast by Region (2026-2031)
Table 8. Global Prostate Cancer Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2020-2025)
Table 10. Global Prostate Cancer Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Prostate Cancer Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2020-2025)
Table 15. Global Prostate Cancer Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Prostate Cancer Diagnostics Application
Table 18. Global Prostate Cancer Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Prostate Cancer Diagnostics Market Share by Players (2020-2025)
Table 20. Global Top Prostate Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics as of 2024)
Table 21. Ranking of Global Top Prostate Cancer Diagnostics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Prostate Cancer Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Prostate Cancer Diagnostics, Headquarters and Area Served
Table 24. Global Key Players of Prostate Cancer Diagnostics, Product and Application
Table 25. Global Key Players of Prostate Cancer Diagnostics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Prostate Cancer Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Prostate Cancer Diagnostics Revenue Market Share by Company (2020-2025)
Table 29. North America Prostate Cancer Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Prostate Cancer Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Prostate Cancer Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Prostate Cancer Diagnostics Revenue Market Share by Company (2020-2025)
Table 33. Europe Prostate Cancer Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Prostate Cancer Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Prostate Cancer Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Prostate Cancer Diagnostics Revenue Market Share by Company (2020-2025)
Table 37. China Prostate Cancer Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Prostate Cancer Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Prostate Cancer Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Prostate Cancer Diagnostics Revenue Market Share by Company (2020-2025)
Table 41. Japan Prostate Cancer Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Prostate Cancer Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Asia Prostate Cancer Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Asia Prostate Cancer Diagnostics Revenue Market Share by Company (2020-2025)
Table 45. Southeast Asia Prostate Cancer Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Asia Prostate Cancer Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 47. India Prostate Cancer Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 48. India Prostate Cancer Diagnostics Revenue Market Share by Company (2020-2025)
Table 49. India Prostate Cancer Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 50. India Prostate Cancer Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 51. OPKO Company Details
Table 52. OPKO Business Overview
Table 53. OPKO Prostate Cancer Diagnostics Product
Table 54. OPKO Revenue in Prostate Cancer Diagnostics Business (2020-2025) & (US$ Million)
Table 55. OPKO Recent Development
Table 56. Genomic Health Company Details
Table 57. Genomic Health Business Overview
Table 58. Genomic Health Prostate Cancer Diagnostics Product
Table 59. Genomic Health Revenue in Prostate Cancer Diagnostics Business (2020-2025) & (US$ Million)
Table 60. Genomic Health Recent Development
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott Prostate Cancer Diagnostics Product
Table 64. Abbott Revenue in Prostate Cancer Diagnostics Business (2020-2025) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. Beckman Coulter Company Details
Table 67. Beckman Coulter Business Overview
Table 68. Beckman Coulter Prostate Cancer Diagnostics Product
Table 69. Beckman Coulter Revenue in Prostate Cancer Diagnostics Business (2020-2025) & (US$ Million)
Table 70. Beckman Coulter Recent Development
Table 71. Siemens Healthcare Company Details
Table 72. Siemens Healthcare Business Overview
Table 73. Siemens Healthcare Prostate Cancer Diagnostics Product
Table 74. Siemens Healthcare Revenue in Prostate Cancer Diagnostics Business (2020-2025) & (US$ Million)
Table 75. Siemens Healthcare Recent Development
Table 76. bioMeriux Company Details
Table 77. bioMeriux Business Overview
Table 78. bioMeriux Prostate Cancer Diagnostics Product
Table 79. bioMeriux Revenue in Prostate Cancer Diagnostics Business (2020-2025) & (US$ Million)
Table 80. bioMeriux Recent Development
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Prostate Cancer Diagnostics Product
Table 84. Roche Revenue in Prostate Cancer Diagnostics Business (2020-2025) & (US$ Million)
Table 85. Roche Recent Development
Table 86. MDx Health Company Details
Table 87. MDx Health Business Overview
Table 88. MDx Health Prostate Cancer Diagnostics Product
Table 89. MDx Health Revenue in Prostate Cancer Diagnostics Business (2020-2025) & (US$ Million)
Table 90. MDx Health Recent Development
Table 91. DiaSorin Company Details
Table 92. DiaSorin Business Overview
Table 93. DiaSorin Prostate Cancer Diagnostics Product
Table 94. DiaSorin Revenue in Prostate Cancer Diagnostics Business (2020-2025) & (US$ Million)
Table 95. DiaSorin Recent Development
Table 96. Myriad Genetics Company Details
Table 97. Myriad Genetics Business Overview
Table 98. Myriad Genetics Prostate Cancer Diagnostics Product
Table 99. Myriad Genetics Revenue in Prostate Cancer Diagnostics Business (2020-2025) & (US$ Million)
Table 100. Myriad Genetics Recent Development
Table 101. Ambry Genetics Company Details
Table 102. Ambry Genetics Business Overview
Table 103. Ambry Genetics Prostate Cancer Diagnostics Product
Table 104. Ambry Genetics Revenue in Prostate Cancer Diagnostics Business (2020-2025) & (US$ Million)
Table 105. Ambry Genetics Recent Development
Table 106. Prostate Cancer Diagnostics Market Trends
Table 107. Prostate Cancer Diagnostics Market Drivers
Table 108. Prostate Cancer Diagnostics Market Challenges
Table 109. Prostate Cancer Diagnostics Market Restraints
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Prostate Cancer Diagnostics Product Picture
Figure 2. Global Prostate Cancer Diagnostics Market Share by Type: 2024 VS 2031
Figure 3. Tumor Biomarker Tests Features
Figure 4. Imaging Features
Figure 5. Biopsy Features
Figure 6. Other Features
Figure 7. Global Prostate Cancer Diagnostics Market Share by Application: 2024 VS 2031
Figure 8. Age Below 55
Figure 9. Age 55-75
Figure 10. Age Above 75
Figure 11. Prostate Cancer Diagnostics Report Years Considered
Figure 12. Global Prostate Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Prostate Cancer Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Prostate Cancer Diagnostics Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Prostate Cancer Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Prostate Cancer Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. China Prostate Cancer Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Japan Prostate Cancer Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Southeast Asia Prostate Cancer Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. India Prostate Cancer Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Central & South America Prostate Cancer Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Global Prostate Cancer Diagnostics Market Share by Players in 2024
Figure 23. Global Top Prostate Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics as of 2024)
Figure 24. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnostics Revenue in 2024
Figure 25. North America Prostate Cancer Diagnostics Market Share by Type (2020-2025)
Figure 26. North America Prostate Cancer Diagnostics Market Share by Application (2020-2025)
Figure 27. Europe Prostate Cancer Diagnostics Market Share by Type (2020-2025)
Figure 28. Europe Prostate Cancer Diagnostics Market Share by Application (2020-2025)
Figure 29. China Prostate Cancer Diagnostics Market Share by Type (2020-2025)
Figure 30. China Prostate Cancer Diagnostics Market Share by Application (2020-2025)
Figure 31. Japan Prostate Cancer Diagnostics Market Share by Type (2020-2025)
Figure 32. Japan Prostate Cancer Diagnostics Market Share by Application (2020-2025)
Figure 33. Southeast Asia Prostate Cancer Diagnostics Market Share by Type (2020-2025)
Figure 34. Southeast Asia Prostate Cancer Diagnostics Market Share by Application (2020-2025)
Figure 35. India Prostate Cancer Diagnostics Market Share by Type (2020-2025)
Figure 36. India Prostate Cancer Diagnostics Market Share by Application (2020-2025)
Figure 37. OPKO Revenue Growth Rate in Prostate Cancer Diagnostics Business (2020-2025)
Figure 38. Genomic Health Revenue Growth Rate in Prostate Cancer Diagnostics Business (2020-2025)
Figure 39. Abbott Revenue Growth Rate in Prostate Cancer Diagnostics Business (2020-2025)
Figure 40. Beckman Coulter Revenue Growth Rate in Prostate Cancer Diagnostics Business (2020-2025)
Figure 41. Siemens Healthcare Revenue Growth Rate in Prostate Cancer Diagnostics Business (2020-2025)
Figure 42. bioMeriux Revenue Growth Rate in Prostate Cancer Diagnostics Business (2020-2025)
Figure 43. Roche Revenue Growth Rate in Prostate Cancer Diagnostics Business (2020-2025)
Figure 44. MDx Health Revenue Growth Rate in Prostate Cancer Diagnostics Business (2020-2025)
Figure 45. DiaSorin Revenue Growth Rate in Prostate Cancer Diagnostics Business (2020-2025)
Figure 46. Myriad Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Business (2020-2025)
Figure 47. Ambry Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Business (2020-2025)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Table 1. Global Prostate Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Prostate Cancer Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Prostate Cancer Diagnostics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Prostate Cancer Diagnostics Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Prostate Cancer Diagnostics Revenue Share by Region (2020-2025)
Table 6. Global Prostate Cancer Diagnostics Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Prostate Cancer Diagnostics Revenue Share Forecast by Region (2026-2031)
Table 8. Global Prostate Cancer Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2020-2025)
Table 10. Global Prostate Cancer Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Prostate Cancer Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2020-2025)
Table 15. Global Prostate Cancer Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Prostate Cancer Diagnostics Application
Table 18. Global Prostate Cancer Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Prostate Cancer Diagnostics Market Share by Players (2020-2025)
Table 20. Global Top Prostate Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics as of 2024)
Table 21. Ranking of Global Top Prostate Cancer Diagnostics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Prostate Cancer Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Prostate Cancer Diagnostics, Headquarters and Area Served
Table 24. Global Key Players of Prostate Cancer Diagnostics, Product and Application
Table 25. Global Key Players of Prostate Cancer Diagnostics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Prostate Cancer Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Prostate Cancer Diagnostics Revenue Market Share by Company (2020-2025)
Table 29. North America Prostate Cancer Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Prostate Cancer Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Prostate Cancer Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Prostate Cancer Diagnostics Revenue Market Share by Company (2020-2025)
Table 33. Europe Prostate Cancer Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Prostate Cancer Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Prostate Cancer Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Prostate Cancer Diagnostics Revenue Market Share by Company (2020-2025)
Table 37. China Prostate Cancer Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Prostate Cancer Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Prostate Cancer Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Prostate Cancer Diagnostics Revenue Market Share by Company (2020-2025)
Table 41. Japan Prostate Cancer Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Prostate Cancer Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Asia Prostate Cancer Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Asia Prostate Cancer Diagnostics Revenue Market Share by Company (2020-2025)
Table 45. Southeast Asia Prostate Cancer Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Asia Prostate Cancer Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 47. India Prostate Cancer Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 48. India Prostate Cancer Diagnostics Revenue Market Share by Company (2020-2025)
Table 49. India Prostate Cancer Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 50. India Prostate Cancer Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 51. OPKO Company Details
Table 52. OPKO Business Overview
Table 53. OPKO Prostate Cancer Diagnostics Product
Table 54. OPKO Revenue in Prostate Cancer Diagnostics Business (2020-2025) & (US$ Million)
Table 55. OPKO Recent Development
Table 56. Genomic Health Company Details
Table 57. Genomic Health Business Overview
Table 58. Genomic Health Prostate Cancer Diagnostics Product
Table 59. Genomic Health Revenue in Prostate Cancer Diagnostics Business (2020-2025) & (US$ Million)
Table 60. Genomic Health Recent Development
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott Prostate Cancer Diagnostics Product
Table 64. Abbott Revenue in Prostate Cancer Diagnostics Business (2020-2025) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. Beckman Coulter Company Details
Table 67. Beckman Coulter Business Overview
Table 68. Beckman Coulter Prostate Cancer Diagnostics Product
Table 69. Beckman Coulter Revenue in Prostate Cancer Diagnostics Business (2020-2025) & (US$ Million)
Table 70. Beckman Coulter Recent Development
Table 71. Siemens Healthcare Company Details
Table 72. Siemens Healthcare Business Overview
Table 73. Siemens Healthcare Prostate Cancer Diagnostics Product
Table 74. Siemens Healthcare Revenue in Prostate Cancer Diagnostics Business (2020-2025) & (US$ Million)
Table 75. Siemens Healthcare Recent Development
Table 76. bioMeriux Company Details
Table 77. bioMeriux Business Overview
Table 78. bioMeriux Prostate Cancer Diagnostics Product
Table 79. bioMeriux Revenue in Prostate Cancer Diagnostics Business (2020-2025) & (US$ Million)
Table 80. bioMeriux Recent Development
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Prostate Cancer Diagnostics Product
Table 84. Roche Revenue in Prostate Cancer Diagnostics Business (2020-2025) & (US$ Million)
Table 85. Roche Recent Development
Table 86. MDx Health Company Details
Table 87. MDx Health Business Overview
Table 88. MDx Health Prostate Cancer Diagnostics Product
Table 89. MDx Health Revenue in Prostate Cancer Diagnostics Business (2020-2025) & (US$ Million)
Table 90. MDx Health Recent Development
Table 91. DiaSorin Company Details
Table 92. DiaSorin Business Overview
Table 93. DiaSorin Prostate Cancer Diagnostics Product
Table 94. DiaSorin Revenue in Prostate Cancer Diagnostics Business (2020-2025) & (US$ Million)
Table 95. DiaSorin Recent Development
Table 96. Myriad Genetics Company Details
Table 97. Myriad Genetics Business Overview
Table 98. Myriad Genetics Prostate Cancer Diagnostics Product
Table 99. Myriad Genetics Revenue in Prostate Cancer Diagnostics Business (2020-2025) & (US$ Million)
Table 100. Myriad Genetics Recent Development
Table 101. Ambry Genetics Company Details
Table 102. Ambry Genetics Business Overview
Table 103. Ambry Genetics Prostate Cancer Diagnostics Product
Table 104. Ambry Genetics Revenue in Prostate Cancer Diagnostics Business (2020-2025) & (US$ Million)
Table 105. Ambry Genetics Recent Development
Table 106. Prostate Cancer Diagnostics Market Trends
Table 107. Prostate Cancer Diagnostics Market Drivers
Table 108. Prostate Cancer Diagnostics Market Challenges
Table 109. Prostate Cancer Diagnostics Market Restraints
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Prostate Cancer Diagnostics Product Picture
Figure 2. Global Prostate Cancer Diagnostics Market Share by Type: 2024 VS 2031
Figure 3. Tumor Biomarker Tests Features
Figure 4. Imaging Features
Figure 5. Biopsy Features
Figure 6. Other Features
Figure 7. Global Prostate Cancer Diagnostics Market Share by Application: 2024 VS 2031
Figure 8. Age Below 55
Figure 9. Age 55-75
Figure 10. Age Above 75
Figure 11. Prostate Cancer Diagnostics Report Years Considered
Figure 12. Global Prostate Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Prostate Cancer Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Prostate Cancer Diagnostics Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Prostate Cancer Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Prostate Cancer Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. China Prostate Cancer Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Japan Prostate Cancer Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Southeast Asia Prostate Cancer Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. India Prostate Cancer Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Central & South America Prostate Cancer Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Global Prostate Cancer Diagnostics Market Share by Players in 2024
Figure 23. Global Top Prostate Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics as of 2024)
Figure 24. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnostics Revenue in 2024
Figure 25. North America Prostate Cancer Diagnostics Market Share by Type (2020-2025)
Figure 26. North America Prostate Cancer Diagnostics Market Share by Application (2020-2025)
Figure 27. Europe Prostate Cancer Diagnostics Market Share by Type (2020-2025)
Figure 28. Europe Prostate Cancer Diagnostics Market Share by Application (2020-2025)
Figure 29. China Prostate Cancer Diagnostics Market Share by Type (2020-2025)
Figure 30. China Prostate Cancer Diagnostics Market Share by Application (2020-2025)
Figure 31. Japan Prostate Cancer Diagnostics Market Share by Type (2020-2025)
Figure 32. Japan Prostate Cancer Diagnostics Market Share by Application (2020-2025)
Figure 33. Southeast Asia Prostate Cancer Diagnostics Market Share by Type (2020-2025)
Figure 34. Southeast Asia Prostate Cancer Diagnostics Market Share by Application (2020-2025)
Figure 35. India Prostate Cancer Diagnostics Market Share by Type (2020-2025)
Figure 36. India Prostate Cancer Diagnostics Market Share by Application (2020-2025)
Figure 37. OPKO Revenue Growth Rate in Prostate Cancer Diagnostics Business (2020-2025)
Figure 38. Genomic Health Revenue Growth Rate in Prostate Cancer Diagnostics Business (2020-2025)
Figure 39. Abbott Revenue Growth Rate in Prostate Cancer Diagnostics Business (2020-2025)
Figure 40. Beckman Coulter Revenue Growth Rate in Prostate Cancer Diagnostics Business (2020-2025)
Figure 41. Siemens Healthcare Revenue Growth Rate in Prostate Cancer Diagnostics Business (2020-2025)
Figure 42. bioMeriux Revenue Growth Rate in Prostate Cancer Diagnostics Business (2020-2025)
Figure 43. Roche Revenue Growth Rate in Prostate Cancer Diagnostics Business (2020-2025)
Figure 44. MDx Health Revenue Growth Rate in Prostate Cancer Diagnostics Business (2020-2025)
Figure 45. DiaSorin Revenue Growth Rate in Prostate Cancer Diagnostics Business (2020-2025)
Figure 46. Myriad Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Business (2020-2025)
Figure 47. Ambry Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Business (2020-2025)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232